Raphi Levy - 21 Aug 2026 Form 4 Insider Report for Alpha Tau Medical Ltd. (DRTS)

Reporting relationship: Chief Financial Officer
Issuer ticker: DRTS
Reported as of: 21 Aug 2026
Net transaction value: -$43,073
SEC form: 4
Accepted by SEC: 25 Aug 2026, 10:34:04 UTC
Prior SEC filing: 12 Aug 2026
Source filing: View source filing
Reporting owner signature: Raphi Levy

Key filing fact

Raphi Levy filed Form 4 for Alpha Tau Medical Ltd. (DRTS) on 25 Aug 2026.

Key facts

This page summarizes Raphi Levy's Form 4 filing for Alpha Tau Medical Ltd. (DRTS).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 25 Aug 2026, 10:34.

Change

Previous filing in this sequence was filed on 12 Aug 2026.
Current net transaction value: -$43,073.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001968095 Primary reporting owner

Levy Raphi

Relationship: Chief Financial Officer
Address: C/O ALPHA TAU MEDICAL, PO BOX 45044, JERUSALEM, ISRAEL
Signature: Raphi Levy
Signature date: 25 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DRTS transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +2,871
Change %: +3.2%
Price: $2.98^*
Shares after: 93,051
Date: 21 Aug 2026
Ownership: Direct

DRTS transaction

Ordinary Shares

Sale

Transaction value: $43,073
Shares: -2,871
Change %: -3.1%
Price: $15.00
Shares after: 90,180
Date: 21 Aug 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).